The Fires of Isengard Have Spread: Serratia sarumanii Is the Dominant Species in Clinical Isolates of the “Serratia marcescens Complex”
Pathogens · 2026
DOI: 10.3390/pathogens15020140 ↗At a glance
Journal article in Pathogens, 2026. Written by Levin Joe Klages and 8 co-authors. Institution: Microbial Genomics and Biotechnology, Center for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany. Major MEDLINE topics: Serratia Infections, Serratia, Serratia marcescens. Cited 3 times so far (Crossref); 27 references. The full text is freely available (open access, CC BY 4.0). Funded by: Federal Ministry of Health, German Federal Ministry of Health, German Research Foundation.
Abstract (original language)
Recently, a new species, Serratia sarumanii, was described, belonging to a group of strains previously identified as Serratia marcescens in routine clinical analyses. It was shown that the identification of S. marcescens isolates by biochemical testing, mass spectrometry, or 16S rRNA gene sequencing was insufficient to resolve the ‘S. marcescens complex’, while sampling point analysis revealed that many genomes assigned to the S. sarumanii cluster were associated with a clinical context. Thus, here the clinical relevance and local as well as global distribution of S. sarumanii is analyzed. In total, 21 strains from three hospitals in Eastern Westphalia-Lippe (OWL), previously identified as S. marcescens and potential causative agents from severe bacterial infections, were analyzed by genome sequencing and species identification. It could be shown that only one isolate was confirmed as S. marcescens, whereas 10 of the 21 isolates were identified as S. sarumanii, indicating that S. sarumanii is the dominant representative of the “Serratia marcescens” complex in hospitals in OWL. To analyze the global species distribution, all Serratia genomes available in GenBank were reclassified. About one-third of these genomes were identified as S. sarumanii, indicating S. sarumanii as the most dominant Serratia species in clinical settings around the world.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Microbial Genomics and Biotechnology, Center for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
- Center for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
- Medical School OWL, Bielefeld University, 33615 Bielefeld, Germany.
- Institute of Laboratory Medicine, Microbiology and Transfusion Medicine, University Medical Center OWL, Bielefeld Hospital, 33615 Bielefeld, Germany.
- Institute of Laboratory Medicine, Microbiology and Hygiene, University Medical Center OWL, Evangelisches Klinikum Bethel, 33615 Bielefeld, Germany.
- Institute of Laboratory Medicine, Microbiology and Clinical Pathobiochemistry, University Medical Center OWL, Klinikum Lippe, 32756 Detmold, Germany.
ORCID profiles: Levin Joe Klages, Julia Hassa, Tobias Busche, Olaf Kaup, Christiane Scherer, Thorsten Kaiser, Jörn Kalinowski, Christian Rückert-Reed
Funding
- Federal Ministry of Health
- German Federal Ministry of Health
- German Research Foundation
- Open Access Publication Fund of Bielefeld University
Cite
APA
Klages, L. J., Hassa, J., Busche, T., Kaup, O., Scherer, C., Freytag, C. C., Kaiser, T., Kalinowski, J., & Rückert-Reed, C. (2026). The Fires of Isengard Have Spread: Serratia sarumanii Is the Dominant Species in Clinical Isolates of the “Serratia marcescens Complex”. Pathogens. https://doi.org/10.3390/pathogens15020140
Vancouver
Klages LJ, Hassa J, Busche T, Kaup O, Scherer C, Freytag CC, et al. The Fires of Isengard Have Spread: Serratia sarumanii Is the Dominant Species in Clinical Isolates of the “Serratia marcescens Complex”. Pathogens. 2026. doi:10.3390/pathogens15020140
BibTeX
@article{Klages2026,
author = {Klages, Levin Joe and Hassa, Julia and Busche, Tobias and Kaup, Olaf and Scherer, Christiane and Freytag, Claudia Christine and Kaiser, Thorsten and Kalinowski, Jörn and Rückert-Reed, Christian},
title = {The Fires of Isengard Have Spread: Serratia sarumanii Is the Dominant Species in Clinical Isolates of the “Serratia marcescens Complex”},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15020140}
}
EUVIMED